Market Cap (In PLN)
457.95 Million
Revenue (In PLN)
516 Thousand
Net Income (In PLN)
-18.78 Million
Avg. Volume
2891.00
- Currency
- PLN
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 141.6-239.0
- PE
- -16.41
- EPS
- -10.24
- Beta Value
- -0.242
- ISIN
- PLSCPFL00018
- CUSIP
- -
- CIK
- -
- Shares
- 2725930.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Piotr Garstecki
- Employee Count
- -
- Website
- https://scopefluidics.com
- Ipo Date
- 2017-08-01
- Details
- Scope Fluidics S.A., a biotechnology company, engages in the designing and developing projects based on microfluidic technologies in medical diagnostics and healthcare. It offers BacterOMIC, an antibiotic susceptibility testing. The company was founded in 2010 and is based in Warsaw, Poland.
More Stocks
-
002331
-
PKCOYPARK24 Co., Ltd.
PKCOY
-
MBGAFMercedes-Benz Group AG
MBGAF
-
DBLVFDoubleview Gold Corp.
DBLVF
-
BBXIABBX Capital, Inc.
BBXIA
-
CTCX
-
BGAVFBravada Gold Corporation
BGAVF
-
NUGNLivento Group, Inc.
NUGN